Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant (NCT07075718)

🧪 Interventions in This Study

• Gen 2 Travoprost Intracameral Implant (DRUG)
• Timolol eye drops 0.5% (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (3 Sites)

• Glaukos Investigative Site — Grand Junction, Colorado
• Glaukos Investigative Site — Oklahoma City, Oklahoma
• Glaukos Clinical Site — El Paso, Texas

📞 Contact the Study Coordinator

Phone: (949) 739-8749

Email: ClinicalResearch@glaukos.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Glaucoma

• Novel Markers for Detecting Early Progression of Glaucoma — Halifax, Nova Scotia
• Electrical Stimulation for the Treatment of Glaucoma — Palo Alto, California
• Visual Field Analysis With Artificial Intelligence — Alexandria, Virginia
• Anterior Segment Optical Coherence Tomography Microstent Positioning — Murray, Utah
• Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination — Santa Rosa de Copán,
• Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma. — Glendale, Arizona

Explore by condition: All Glaucoma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.